Single fraction urethra-sparing prostate cancer SBRT: Phase I results of the ONE SHOT trial
- PMID: 31431369
- DOI: 10.1016/j.radonc.2019.07.018
Single fraction urethra-sparing prostate cancer SBRT: Phase I results of the ONE SHOT trial
Abstract
The ONE SHOT trial is the first phase I/II prospective, multicenter, single-arm study assessing the efficacy and safety of a single-dose SBRT for men with localized prostate cancer. Aim of this paper is to present the phase I results of a 19 Gy single fraction urethra-sparing SBRT with real-time electromagnetic tracking.
Keywords: Monotherapy; Phase I/II trial; Prostate cancer; SBRT; Toxicity.
Copyright © 2019 Elsevier B.V. All rights reserved.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
